{"mainPropery":{"diseaseId":6226,"diseaseName":"Cutaneous T-cell lymphoma","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/6226/cutaneous-t-cell-lymphoma","synonyms":["CTCL"],"synonyms-with-source":[{"name":"CTCL"}],"identifiers":[{"identifierType":"ORPHANET","identifierId":"171901"},{"identifierType":"UMLS","identifierId":"C0079773"}]},"diseaseCategories":[{"diseaseTypeId":1,"diseaseTypeName":"Rare Cancers"}],"organizations":[{"resourceID":462,"resourceName":"Cutaneous Lymphoma Foundation","abbreviation":"","address1":"PO Box 374","address2":"","address3":"","address4":"","address5":"","city":"Birmingham","state":"MI","zip":"48012","country":"United States","phone":"+1-248-644-9014","tty":"","tollFree":"","fax":"+1-248-644-9014","email":"info@clfoundation.org","url":"https://www.clfoundation.org/","freeText":"Facebook: https://www.facebook.com/clfoundation"},{"resourceID":570,"resourceName":"Leukemia and Lymphoma Society","abbreviation":"","address1":"3 International Drive, Suite 200","address2":"","address3":"","address4":"","address5":"","city":"Rye Brook","state":"NY","zip":"10573","country":"United States","phone":"1-(888) 557-7177 (general)","tty":"","tollFree":"1-(800) 955-4572 (patients and families)","fax":"","email":"https://www.lls.org/content/contact-us","url":"https://www.lls.org/","freeText":""}],"resource descriptions":[{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=DetailsSearch&Term=(Cutaneous%5BTitle%5D+AND+T-cell%5BTitle%5D+AND+lymphoma%5BTitle%5D)+NOT+B%5BTitle%5D+AND+(%22loattrfree+full+text%22%5Bsb%5D+AND+%222004%2F10%2F25%22%5BPDat%5D+%3A+%222009%2F10%2F23%22%5BPDat%5D+AND+%22humans%22%5BMeSH+Terms%5D+AND+English%5Blang%5D)' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Cutaneous T-cell lymphoma. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://www.clinicaltrials.gov/ct2/results?cond=%22Cutaneous+T-cell+lymphoma%22' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Cutaneous T-cell lymphoma. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":1527,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"The <a href='http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/1124/viewAbstract' target='_blank'>National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://emedicine.medscape.com/article/209091-overview' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=171901' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1543,"resourceId":2171,"resourceName":"National Cancer Institute","descriptionText":"The <a href='http://www.cancer.gov/cancertopics/types/non-hodgkin' target='_blank'>National Cancer Institute</a> provides the most current information on cancer for patients, health professionals, and the general public.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1550,"resourceId":2178,"resourceName":"DermNet New Zealand","descriptionText":"<a href='http://dermnetnz.org/dermal-infiltrative/cutaneous-t-cell-lymphoma.html' target='_blank'>DermNet NZ</a> is an online resource about skin diseases developed by the New Zealand Dermatological Society Incorporated. DermNet NZ provides information about this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/DOID:0060061' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2160,"resourceId":3368,"resourceName":"Patient Access Network Foundation","descriptionText":"<a href='https://panfoundation.org/index.php/en/patients/assistance-programs/cutaneous-t-cell-lymphoma' target='_blank'>Patient Access Network Foundation</a> (PAN Foundation) has Assistance Programs for those with health insurance who reside in the United States. The disease fund status can change over time, so you may need to check back if funds are not currently available.&nbsp;","resourceClassificationName":"Living With","resourceClassificationSectionName":"Financial Resources"}],"overviewQuestion":{"questionId":5358,"questionText":"What are cutaneous T-cell lymphomas?","answerText":"<strong>Cutaneous T-cell lymphomas (CTCLs)</strong> are a group of disorders&nbsp;characterized by an abnormal accumulation of cancerous <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003516.htm\" target=_blank>T-cells</a> (a type of white blood cells) in the skin&nbsp;resulting in&nbsp;an itchy, red rash that can thicken or form a tumor. CTCLs belong to a larger group of disorders known as<a target=_blank>non-Hodgkin's lymphomas</a>. The most common types are <a href=\"http://rarediseases.info.nih.gov/GARD/Condition/3863/Mycosis_fungoides.aspx\" target=_blank>mycosis fungoides</a>&nbsp;and <a href=\"http://rarediseases.info.nih.gov/GARD/Condition/7629/Sezary_syndrome.aspx\" target=_blank>SÃ©zary syndrome</a>. In some cases, cancerous T-cells&nbsp;may spread to the <a href=\"http://www.nlm.nih.gov/medlineplus/ency/imagepages/19672.htm\" target=_blank>lymph nodes</a>&nbsp;and eventually to other body tissues and organs, potentially resulting in life-threatening complications. The specific signs and&nbsp;symptoms vary from person to person. The exact cause of these conditions is unknown.[4417]","dateModified":"2011-09-27T17:00:00"},"basicQuestions":[],"references":[],"relatedDiseases":[{"relatedDiseaseId":11955,"relatedDiseaseName":"Lymphoma","relation":"Parent","isRare":false,"hasGardPage":false},{"relatedDiseaseId":3863,"relatedDiseaseName":"Mycosis fungoides","relation":"Child","isRare":true,"hasGardPage":true},{"relatedDiseaseId":7629,"relatedDiseaseName":"Sezary syndrome","relation":"Child","isRare":true,"hasGardPage":true}],"gardCases":[],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[],"medicalProducts":[{"productId":506,"genericName":"Romidepsin","tradeName":"Istodax","tradeLink":"http://www.istodax.com/","manufacturer":"","sponsor":"Gloucester Pharmaceuticals, Inc.","indication":"Treatment of cutaneous T-cell lymphoma (CTCL) in patients who have received at least one prior systemic therapy ","drugInformationLink":"http://druginfo.nlm.nih.gov/drugportal/dpdirect.jsp?name=ROMIDEPSIN","medlinePlusLink":""},{"productId":143,"genericName":"Denileukin diftitox","tradeName":"Ontak","tradeLink":"","manufacturer":"","sponsor":"Eisai Medical Research, Inc.","indication":"Treatment of patients with persistent or recurrent cutaneous T-cell lymphoma whose malignant cells express the CD25 component of the IL-2 receptor.","drugInformationLink":"https://druginfo.nlm.nih.gov/drugportal/rn/173146-27-5","medlinePlusLink":"https://medlineplus.gov/druginfo/meds/a611024.html"},{"productId":141,"genericName":"Bexarotene","tradeName":"Targretin (topical)","tradeLink":"http://www.targretin.com/","manufacturer":"","sponsor":"Eisai Medical Research, Inc.","indication":"Treatment of cutaneous manifestations of cutaneous T-cell lymphoma in patients who are refractory to at least one prior systemic therapy.","drugInformationLink":"https://druginfo.nlm.nih.gov/drugportal/name/Targretin","medlinePlusLink":"https://medlineplus.gov/druginfo/meds/a608006.html"}],"EncodedName":"Cutaneous_T-cell_lymphoma"}